Press
High-Tech Gründerfonds (HTGF), MBG and Wayra invest EUR 800,000
AI start-up 5Analytics receives follow-up financing
5Analytics, the start-up behind Telefónica Germany's Analytical Insight Center (AIC), has secured a new round of financing from a prominent group of investors. The Stuttgart-based start-up plans to use the fresh capital to expand its team, develop its products and acquire new clients. In addition to Wayra, HTGF and MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg within the Seedfonds BW are among the investors participating
Press
The game changer in surgical education – breaking bones for better patient outcomes
Cologne based MedTech start-up RIMASYS received financing from investor HTGF. The investment will be utilized to expand the fracture portfolio, upgrade production technology and increase international reach. RIMASYS is the worldwide sole manufacturer of life-like fractures in human specimen with intact soft tissue mantle. Enabling medical science to enhance surgical skills and the health care industry to develop better implants will result in improved patient outcomes at a lower cost of care. No
Press
BORN2GROW supports biotech start-up Venneos with its further growth
Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q – a silicon chip-based imaging system for analysing biological cells.
“We are thrilled to have BORN2GROW on-board as a new investor, and that we will be able to benefit from its extensive expertise in the field of life sciences,” says David Wehner, one of the co-founders and co-directors of Venneos GmbH.
Press
Atriva reaches a development milestone and receives an additional tranche of running seed financing to develop its influenza therapeutic to clinical stage
The next generation of Antiviral Therapies: Co-Led by Stichting Participatie Atriva and High-Tech Gründerfonds (HTGF), Atriva Therapeutics GmbH has received a second tranche of its running seed financing in total of € 3 Mn from Dutch, German and Canadian investors, after lead compound ATR-002 (Atriva’s antiviral MEK-Inhibitor against Influenza) has passed an important preclinical milestone paving the way to clinical development stage.
Atriva Therapeutics stands for the next generation of
Press
Coredinate secures follow-on financing
New investor MWN Equity Investment and Bayern Kapital Innovationsfonds ERFE take stake
Coredinate, a software-as-a-service (Saas) company based in Uffenheim, Bavaria, has successfully closed a €1.9 million financing round. Alongside existing investors such as High-Tech Gründerfonds, Bayern Kapital has invested in the firm once again – this time using funds from its innovation fund BayernKapital Innovationsfonds ERFE, which replaces SeedFonds Bayern, the vehicle used for its previous inve
Press
Evonik is investing in NUMAFERM, a specialist in the biotechnological production of peptides
NUMAFERM makes the production of peptides more efficient
Investment strengthens Evonik’s growth engines Health & Care and Specialty Additives at Evonik
New technical applications are becoming realistic for the first time
Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now holds a minority share in the spin-off of Heinrich Heine University Düsseldorf. The investment was made as part of a seed financing round and also includes investments by H
Press
High-Tech Gründerfonds starts lining up investments for HTGF III fund
Europe’s most active seed-stage investor announces first investments from third fund, HTGF III
High-Tech Gründerfonds’ third fund is now operational After announcing the successful first close at the 2017 Family Day – the biggest event of the year for the venture capital sector in Germany – HTGF has now begun approving investments from the new fund. The launch coincides with HTGF’s publication of new investment terms.
This week sees the first investment decisions being made
Press
Reactive Robotics GmbH is on track
Clinical validation, market entry in Germany and further countries secured by second investment round with existing and new investors
Founded in 2015 in Munich, Reactive Robotics GmbH is a medical device start-up with the corporate objective to provide the best possible Very Early Mobilization (VEM) to intensive care patients as early as 24 hours after hospital admission, directly in the patient’s bed. Amongst experts, VEM is regarded as one of the key factors contributing to the faster rec
Press
Investors sell their shares in the fastener company FIDLOCK
Investors sell their shares in the fastener company FIDLOCK
The Wuppertal based business man Ralf Putsch purchases the majority shares in FIDLOCK GmbH.
Founded by Joachim Fiedler in 2007, the Hannover based FIDLOCK GmbH has made a name for itself in the world of fasteners. FIDLOCK designs and produces fasteners that combine the benefits of side release buckles and magnet fasteners. These patented concepts have already established themselves in the school bag industry, as well as for bike a
Press
Deutsche Börse Venture Network and High-Tech Gründerfonds enter into cooperation
Deutsche Börse Venture Network and High-Tech Gründerfonds (HTGF) have formalised their existing collaboration by signing a cooperation agreement. The aim of the partnership is to continue linking existing programmes with each other to closely support start-ups throughout their entire funding and growth phase.
HTGF is the first point of contact for all matters relating to early stage financing; the portfolio companies receive a reduced-rate membership in Deutsche Börse Venture Network, givi
Press
Compositence GmbH gains GON Holding as strategic partner
Chinese advanced material manufacturer GON Holding takes majority stake in Compositence
Compositence GmbH, specializing in innovative Preforming Technologies for Carbon, Glass and other fibre types and supplier of tailored preforms wins Chinese advanced material manufacturer as a new strategic partner for its future development.
High-Tech Gründerfonds and MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg have been supporting Compositence growth by initial funding in 2009.
Press
FlyNex: Seven-digit seed-round for drone software
German DroneTech company FlyNex, founded by former special ops officers, raises big seed round. The co-investment by TGFS and HTGF ensures the implementation of the drone business software into industrial enterprises. The software empowers these companies to use drones for own applications, without having deeper technological and legal knowledge.
The DroneTech start up FlyNex closes a seven-digit seed round and extends its offices in Leipzig and Hamburg. With a co-investment by Technologiegr
Press
Neu-Ulm-based medical device producer and High-Tech Gründerfonds found spin-off Zimmer BioTech: New therapy to combat skin cancer
In the field of dermatology, Zimmer MedizinSysteme GmbH, a company based in Neu-Ulm (southern Germany), has long been the global market leader for cryotherapy products. In founding the spin-off Zimmer BioTech, the company is now taking another step forward and utilising its wealth of experience to treat skin cancer. Together with High-Tech Gründerfonds (HTGF), the medical device producer is investing in the development of a drug based on the compound 5-Aminolevulinic acid (ALA), which is used i
Press
Selfapy secures seven-figure funding
High-Tech Gründerfonds (HTGF), IBB Beteiligungsgesellschaft and experienced business angels invested a seven-figure sum in the Digital Health start-up Selfapy in July. Selfapy offers scientifically proven online therapy courses that make fast and affordable care easily accessible to people with mental disorders such as depression, eating disorders and anxiety. “The funding enables us to help even more people suffering from mental illness. In the end, it is our goal to cooperate with health in
Press
Specialty biotech company Advanced Enzymes acquires HTGF Portfolio company evoxx technologies
The industrial biotechnology company evoxx technologies GmbH has become a part of the leading specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a binding agreement about the acquisition of 100% stake in evoxx technologies.
evoxx technologies is proud to announce that it will become part of the global enzyme manufacturing company Advanced Enzyme Technologies Limited. evoxx and its team of 35+ scientists & technicians across
Press
High-Tech Gründerfonds (HTGF) and MBG invest in stimOS’ Mimicking Bone Technologies: Constance-based Start-Up Company gains HTGF and MBG as investors
German HTGF acts as seed investor at stimOS GmbH located in Constance: Together with MBG, Baden-Württemberg (MBG), the seed stage investor provides 720,000 euros for further development and approval of stimOS’ patented Mimicking Bone Technology (MBT). To ensure best possible recovery for the patient and achieve a pain-free life after surgery, stimOS GmbH has developed a unique biochemical procedure that initiates early and healthy bone formation, anti-inflammatory activity, and faster healing